Share on StockTwits

SunOpta (NASDAQ:STKL) has earned a consensus recommendation of “Buy” from the ten ratings firms that are presently covering the stock, American Banking & Market News reports. One analyst has rated the stock with a sell rating, one has given a hold rating and seven have issued a buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $13.13.

SunOpta (NASDAQ:STKL) traded up 0.12% during mid-day trading on Thursday, hitting $13.827. 31,378 shares of the company’s stock traded hands. SunOpta has a 52 week low of $7.97 and a 52 week high of $14.20. The stock’s 50-day moving average is $13.32 and its 200-day moving average is $11.2. The company’s market cap is $922.1 million.

SunOpta (NASDAQ:STKL) last issued its quarterly earnings data on Tuesday, May 13th. The company reported $0.10 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.08 by $0.02. The company had revenue of $333.50 million for the quarter, compared to the consensus estimate of $297.27 million. Analysts expect that SunOpta will post $0.44 EPS for the current fiscal year.

A number of research firms have recently commented on STKL. Analysts at Citigroup Inc. reiterated a “buy” rating on shares of SunOpta in a research note on Tuesday, June 17th. They now have a $15.00 price target on the stock, up previously from $12.00. Separately, analysts at Northland Securities raised their price target on shares of SunOpta from $11.50 to $15.00 in a research note on Thursday, May 15th. They now have an “outperform” rating on the stock. Finally, analysts at Desjardins downgraded shares of SunOpta from a “hold” rating to a “sell” rating in a research note on Thursday, April 17th. They now have a $10.25 price target on the stock, up previously from $8.50.

SunOpta Inc (NASDAQ:STKL) is a global company operating businesses focused on a healthy products portfolio that promotes sustainable well-being.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.